More on MBX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MBX Biosciences (NQ:MBX)
Delayed: 62.92 +4.60 (7.89%)
Prev. Close $58.32  
Open$55.93 
52 Wk High$ 
52 Wk Low$ 
Day High$63.09 
Day Low$55.42 
P/E N/A  
EPS$ 
Volume898,458 

Friends, Peers and Foes (?): MBXBF, AEMD, COCH, SNGX, KLRA (more...)

Jul 15, 2026 08:30 AM Attovia Therapeutics names John Smither to board of directors
Jul 15, 2026 08:30 AM Attovia Therapeutics Appoints John W. Smither to Board of Directors
Jul 13, 2026 04:46 PM Form 8-K MBX Biosciences, Inc. For: Jul 09
Jul 13, 2026 04:15 PM MBX Biosciences names new CEO and CFO amid leadership shift
Jul 13, 2026 04:15 PM MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
Jul 8, 2026 12:59 PM Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Jul 8, 2026 10:12 AM Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: FMR LLC
Jun 24, 2026 04:06 PM Form SCHEDULE 13G MBX Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
Jun 12, 2026 07:06 AM Form 8-K MBX Biosciences, Inc. For: Jun 12
Jun 12, 2026 07:01 AM MBX Biosciences reports sustained one-year data for weekly drug trial
View All Articles

Entities mentioned with MBX

View All Entities